Science Explorer Interactive view Map
City · Switzerland

Research in Épalinges

Science Explorer records 2 research institutions in Épalinges, Switzerland. The largest by output are Adc Therapeutics (Switzerland) and Med Discovery (Switzerland).

Research institutions
2
Research works
53
▲ 204% vs 2013–17
Top-10% rate, 2022–2025
7.3%
record average 16.5%

A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.

Which research institutions are in Épalinges?

#InstitutionWorksAgainst the largest hereWorld rank
1Adc Therapeutics (Switzerland)Company 34 not ranked
2Med Discovery (Switzerland)Company 18 not ranked

By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.

Which keywords describe research in Épalinges?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Cancer Immunotherapy, Rituximab, Immunotherapy, Tumor Regression, Leukemia, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Lymphoma5▲ 132×3 topics
  2. Cancer Immunotherapy4▲ 118×3 topics
  3. Rituximab4▲ 116×3 topics
  4. Immunotherapy4▲ 23×8 topics
  5. Tumor Regression4▲ 132×2 topics
  6. Leukemia4▲ 169×2 topics
  7. CAR T Cells3▲ 187×1 topic
  8. Chimeric Antigen Receptor3▲ 187×1 topic
  9. Prognostic Factors3▲ 26×5 topics
  10. Chronic Lymphocytic Leukemia2▲ 224×1 topic
  11. Genomic Aberrations2▲ 224×1 topic
  12. Therapeutic Targets2▲ 68×2 topics
  13. Glycosylation2▲ 84×3 topics
  14. PET Imaging2▲ 53×3 topics
  15. Molecular Profiling2▲ 73×2 topics
  16. Monoclonal Antibodies2▲ 82×2 topics
  17. Cancer Therapy2▲ 12×7 topics
  18. Classification2▲ 15×1 topic
  19. Fc Receptors2▲ 127×1 topic
  20. Genetic Pathogenesis2▲ 130×1 topic
  21. Therapeutic Antibodies2▲ 100×1 topic

What research is done in Épalinges?

CAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksChronic Lymphocytic Leukemia Research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksLymphoma Diagnosis and T…2Lymphoma Diagnosis and Treatment: 2 fractional worksImmunotherapy and Immune Responses: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksUbiquitin and proteasome pathways: 1 fractional worksTransplantation: Methods and Outcomes: 0 fractional worksBiomedical Ethics and Regulation: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional works
OncologyGeneticsRadiology, Nuclear Medicine and ImagingPathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 1 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 1 works
  8. 8 Transplantation: Methods and Outcomes Surgery 0 works
  9. 9 Biomedical Ethics and Regulation Physiology 0 works
  10. 10 Chronic Myeloid Leukemia Treatments Hematology 0 works

Research output over time

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more.